Application of Curve Resolution Algorithms in the Study of Drug Photodegradation Kinetics—The Example of Moclobemide : Chemometrics in Pharmaceutical AnalysisSKIBINSKI, Robert; KOMSTA, Lukasz.Journal of AOAC International. 2012, Vol 95, Num 3, pp 708-712, issn 1060-3271, 5 p.Article

Death following acute poisoning by moclobemideGIROUD, Christian; HORISBERGER, Beat; CHIN EAP et al.Forensic science international. 2004, Vol 140, Num 1, pp 101-107, issn 0379-0738, 7 p.Article

Efficacy of moclobemide in a rat model of neurotoxicant-induced edemaGIRARD, Philippe; VERNIERS, Danielle; PANSART, Yannick et al.Canadian journal of physiology and pharmacology. 2007, Vol 85, Num 5, pp 556-561, issn 0008-4212, 6 p.Article

Aurorix : Generic name : MoclobemideSNAPE, M; MALLARKEY, G.Current therapeutics. 1996, Vol 37, Num 5, pp 87-88, issn 0311-905XArticle

Moclobemide attenuates anoxia and glutamate-induced neuronal damage in vitro independently of interaction with glutamate receptor subtypesVERLEYE, Marc; STEINSCHNEIDER, Remy; BERNARD, Francois Xavier et al.Brain research. 2007, Vol 1138, pp 30-38, issn 0006-8993, 9 p.Article

The effect of augmentation with moclobemide on symptoms of schizophreniaSILVER, H; AHARON, N; HAUSFATER, N et al.International clinical psychopharmacology. 1999, Vol 14, Num 3, pp 193-195, issn 0268-1315Article

Anxiolytic and memory improving effects of moclobemideNOWAKOWSKA, E; CHODERA, A; KUS, K et al.Arzneimittel-Forschung. 1998, Vol 48, Num 6, pp 625-628, issn 0004-4172Article

Antidépresseurs et stimulation sexuelle : la part des choses = Antidepressants and sexual stimulation : is it a reality ?CHEBILI, S; ABAOUB, A; MEZOUANE, B et al.L' Encéphale (Paris). 1998, Vol 24, Num 3, pp 180-184, issn 0013-7006Article

Spectrophotometric determination of moclobemide by charge-transfer complexationADIKWU, M. U; OFOKANSI, K. C.Journal of pharmaceutical and biomedical analysis. 1997, Vol 16, Num 3, pp 529-532, issn 0731-7085Article

Social phobia : the need for treatmentMONTGOMERY, S. A.International clinical psychopharmacology. 1997, Vol 12, pp S3-S9, issn 0268-1315, SUP6Conference Paper

A case of serotonin syndrome induced by moclobemide during an extreme heatwaveBUTZKUEVEN, H.Australian and New Zealand journal of medicine. 1997, Vol 27, Num 5, pp 603-604, issn 0004-8291Conference Paper

Hyponatrémie sévère induite par le moclobémide = Severe hyponatremia induced by moclobemideMERCIER, S; HARRY, P; MERIT, J. B et al.Thérapie (Paris). 1997, Vol 52, Num 1, pp 82-83, issn 0040-5957Conference Paper

Moclobemide effects on prolactin plasma levels in healthy individuals : the hormonal increase induced by a single dose is maintained during a 4-week period of drug intakeJURUENA, M. F; PIRES, M. L. N; CALIL, H. M et al.International clinical psychopharmacology. 1997, Vol 12, Num 6, pp 317-321, issn 0268-1315Article

Meta-analysis of the reversible inhibitors of monoamine oxidase type a moclobemide and brofaromine for the treatment of depressionLOTUFO-NETO, F; TRIVEDI, M; THASE, M. E et al.Neuropsychopharmacology (New York, NY). 1999, Vol 20, Num 3, pp 226-247, issn 0893-133XArticle

A randomized, double-blind, placebo-controlled study of moclobemide and amitriptyline in the treatment of fibromyalgia in females without psychiatric disorderHANNONEN, P; MALMINIEMI, K; YLI-KERTTULA, U et al.British journal of rheumatology. 1998, Vol 37, Num 12, pp 1279-1286, issn 0263-7103Article

An open-label, controlled study of citalopram versus moclobemide in patients with major depressionCASTANEDO DE ALBA, L; MEIXUEIRO-MONTES DE OCA, R.Current therapeutic research. 1998, Vol 59, Num 2, pp 107-115, issn 0011-393XArticle

Moclobemida : Interações medicamentosas = Moclobemide : Pharmacokinetic interactionsRUMI, D. O; MARCOLIM, M. A.Psiquiatria biológica (Belo Horizonte). 1998, Vol 6, Num 3, pp 139-144, issn 0104-7787Article

Pharmacotherapy of dysthymia : review and new findingsVERSIANI, M; NARDI, A. E; FIGUEIRA, I et al.European psychiatry. 1998, Vol 13, Num 4, pp 203-209, issn 0924-9338Article

An open trial of moclobemide in the treatment of post-traumatic stress disorderNEAL, L. A; SHAPLAND, W; FOX, C et al.International clinical psychopharmacology. 1997, Vol 12, Num 4, pp 231-237, issn 0268-1315Article

Interactive model of therapeutic response in panic disorder: Moclobemide, a case in pointUHLENHUTH, E. H; WARNER, Teddy D; MATUZAS, William et al.Journal of clinical psychopharmacology. 2002, Vol 22, Num 3, pp 275-284, issn 0271-0749Article

Selective mutism, social phobia and moclobemide : A case reportMASKEY, Sean.Clinical child psychology and psychiatry. 2001, Vol 6, Num 3, pp 363-369, issn 1359-1045Article

Is the efficacy of topical corticosteroid therapy for psoriasis vulgaris enhanced by concurrent moclobemide therapy? A double-blind, placebo-controlled studyALPSOY, E; ÖZCAN, E; CETIN, L et al.Journal of the American Academy of Dermatology. 1998, Vol 38, Num 2, pp 197-200, issn 0190-9622, 1Article

Moclobemid treatment in primary fibromyalgia syndromeYAVUZER, G; KAPAKDEVECI, A; ARASIL, T et al.European journal of physical medicine & rehabilitation. 1998, Vol 8, Num 2, pp 35-38, issn 1017-6721Article

Moclobemide versus fluoxetine in the treatment of major depressive disorder in adultsLAPIERRE, Y. D; JOFFE, R; ANNABLE, L et al.Journal of psychiatry & neuroscience. 1997, Vol 22, Num 2, pp 118-126, issn 1180-4882Article

Social phobia : long-term treatment outcome and prediction of response : a moclobemide studyVERSIANI, M; AMREIN, R; MONTGOMERY, S. A et al.International clinical psychopharmacology. 1997, Vol 12, Num 5, pp 239-254, issn 0268-1315Article